*All of our Dermatology clinical trials require onsite visits at our Specalisit clinic located in the Canberra suburb of Woden.
This clinical trial is testing an investigational mRNA-based acne vaccine for adults aged 18-45 with moderate to severe acne. The study aims to evaluate the vaccine's safety and effectiveness by targeting C. acnes bacteria, which contribute to inflammation and acne development. Participants would need to complete 13 in-person visits to our clinic over approximately 8 months, selected participants will be given the option to be followed up for 3 years.
Apply Now
